Tower Research Capital LLC (Trc) Bausch Health Companies Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,586 shares of BHC stock, worth $16,639. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,586
Previous 2,664
34.61%
Holding current value
$16,639
Previous $21,000
9.52%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding BHC
# of Institutions
271Shares Held
242MCall Options Held
3.66MPut Options Held
11.3M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$161 Million3.02% of portfolio
-
Goldentree Asset Management LP New York, NY30.3MShares$140 Million17.26% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$123 Million9.81% of portfolio
-
Nomura Holdings Inc Tokyo, M023.4MShares$109 Million0.32% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$60.3 Million0.19% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $1.68B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...